Trastuzumab Not Yet Recruiting Phase 3 Trials for Neoplasms, Breast Other

IndicationsStatusPurposePhase
Not Yet RecruitingOther3
clinicaltrials.gov IdentifierTitleDrugs
NCT03705429A Study Comparing Two Standard of Care Adjuvant Chemotherapy Regimens for Lower Risk HER-2 Positive Breast Cancer